Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
REGN
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
REGN: Regeneron Pharmaceuticals, Inc. Stock Analysis | finqOS
REGN
$920.69
−0.19%
Lists
Call REGN
Regeneron Pharmaceuticals
REGN
Back
Lists
Call REGN
$920.69
−$1.71 · −0.19%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Up
10%
in three months and
82%
of the way up its 52-week range.
Call REGN
Loading chart data...
Signal state